The active humidifier devices market generated a revenue of US$ 1,558.6 million in 2022. It is gradually declining at a (-) 0.5% CAGR, thus recording US$ 1,264.4 million in 2023. By 2033, the market is expected to be contracted to US$ 1,206.9 million, as forecasted by Future Market Insights.
Demand for active humidifier devices is mostly driven by the increased prevalence of obstructive respiratory diseases. Due to the outbreak of previously unknown infectious diseases that affect respiratory systems, the adoption of active humidifier devices surged in the historical period. Further, the application of humidifier devices in invasive ventilation accounted for nearly 47% of sales in 2022.
| Attribute | Details |
|---|---|
| Active Humidifier Devices Market Size (2023) | US$ 1,264.4 million |
| Active Humidifier Devices Market Size (2033) | US$ 1,206.9 million |
| Active Humidifier Devices Industry CAGR (2023 to 2033) | -0.5% CAGR |
| Active Humidifier Devices Market Size (2022) | US$ 1,558.6 million |
| Active Humidifier Devices Market Size (2017) | US$ 442 million |
| Active Humidifier Devices Industry CAGR (2017 to 2022) | 28.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Refining healthcare infrastructure and surging medical expenditure by governments are expected to support to set up and usage of advanced medical devices across various institutes. These institutes include hospitals, ambulatory surgical centers, primary healthcare units, and sleep care institutes.
Technological advancements have led to the expanding use of active respiratory humidifiers across various applications across care. Apart from the general hospitals' wards to critical care units, bubble humidifiers are now being found compatible to be used in MRI settings.
Agreements, partnerships, and collaborations have surfaced as main growth strategies implemented by the leading players in the active humidifier devices industry. Followed by this, new product launches emerged as the second-leading strategy adopted by the key players in the market. Further, these strategies help the companies to expand their product offerings to enhance respiratory care. Acquisitions of key companies significantly accelerate the manufacturer’s plan to capture more market share.
Improvement and streamlining of regulatory processes in developing countries are expected to boost
The manufacturers are realizing the low returns in this market despite these opportunities, considering the gradually reducing market size. Without beneficial prospects, manufacturers are most likely to turn down development proposals.
Principal Consultant
According to Future Market Insights (FMI), the sales of active humidifier devices market expanded at a CAGR of 28.7% between 2018 and 2022. During this period, the growing respiratory distress due to the COVID-19 virus had created a sharp rise in the adoption of ventilators the world over.
Demand for active humidifier devices increased during the pandemic as humidifiers are deployed to offer humidified air to patients who need respiratory assistance. Increased demand for crucial life-saving instruments such as medical ventilators, and high-flow oxygen therapy devices due to the sudden outbreak of COVID-19 motivated the market growth in the historical period.
The emergence of infectious diseases affecting respiratory systems and acceptance of high-flow nasal cannulas for oxygen therapy is anticipated to sustain the sales of active humidifier devices over the forecast period. Moreover, demand for active humidifier devices is primarily driven by improving healthcare infrastructure, increasing medical expenditure, and the high prevalence of respiratory diseases across the globe.
Integration of technologically advanced new solutions to meet patients' expanding respiratory needs is a primary reason for the intense competition in the market worldwide. Leading companies are concentrating on product unveilings and innovations or obtaining approvals for their new products to generate reasonable revenues.
Key manufacturers in this industry are hit severely since COVID cases have petered out. According to Future Market Insights, the global active humidifier devices industry is poised to register a CAGR of -0.5% from 2023 to 2033.
| Historical CAGR (2018 to 2022) | 28.7% |
|---|---|
| Forecast CAGR (2023 to 2033) | -0.5% |
The market forecast is expected to be challenging for manufacturers, as the sales have been estimated to dwindle from US$ 1,264.4 million in 2023 to US$ 1,206.9 million by 2033.
The shriveling market size can be credited to the ease of COVID-19 cases. Other factors that are also contributing to the declining market include:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Active Humidifier Devices Market:
| Attributes | Active Humidifier Devices Market |
|---|---|
| CAGR (2023 to 2033) | -0.5% |
| Market Value (2023) | US$ 1,264.4 million |
| Opportunity | Betterment and streamlining of regulatory processes are expected to attract players in the market. However, growth opportunities are expected to lessen over the years. |
| Key Trends | Intense competition from rivalries keeps market players on their toes. |
Medical Ventilators Market:
| Attributes | Medical Ventilators Market |
|---|---|
| CAGR (2023 to 2033) | 9.1% |
| Market Value (2023) | US$ 1.7 billion |
| Opportunity | The surging geriatric population offers growth prospects for manufacturers. |
| Key Trends | Manufacturers are maintaining their competitiveness by investing in their capabilities like expending on microprocessors. |
High-flow Ventilators Market:
| Attributes | High-flow Ventilators Market |
|---|---|
| CAGR (2023 to 2033) | 10% |
| Market Value (2023) | US$ 29.7 billion |
| Opportunity | Increasing chronic obstructive pulmonary disease and cancer incidences. |
| Key Trends | Growing efforts for providing cost-effective surgeries. |
| Country | The United States |
|---|---|
| Market Share % (2022) | 27.8% |
In 2022, the United States accounted for over 94% value share in North America. The need for active humidifier devices saw heightened demand in the United States due to the unprecedented outbreak of COVID-19.
A large number of patients suffering from COVID-19 have driven the need for active humidifier devices for survival. Due to the significant need for these devices, the market witnessed positive growth during the historical period.
The market is projected to be driven by rising affordability to treat respiratory diseases, an increasing number of tracheostomies executed for different diseases and health consciousness.
| Country | Germany |
|---|---|
| Market Share % (2022) | 4% |
Germany is expected to account for over 32.3% of the market in Europe by 2033, opines Future Market Insights. The rise in demand for active humidifier devices is primarily due to increasing health awareness.
The sudden outbreak of the COVID-19 epidemic increased the demand for active humidifier diseases to curb the increasing mortality rates due to the pandemic. Further, the technological advancements and the adoption of heated/electronic humidifier devices are likely to offer up new opportunities for the active humidifier devices industry players in Germany.
| Country | China |
|---|---|
| Market CAGR % (2023 to 2033) | 1.5% |
As per Future Market Insights, China’s active humidifier devices market is expected to account for over 49.5% of the market across East Asia by 2033. The high prevalence of respiratory diseases in the country is a key factor driving market growth.
Demand for active humidifier devices witnessed a sudden spike in the historical period as China was the first country to witness the spread of COVID-19. With surged cases, the need for active humidifier devices increased, spurring sales during that period.
In China, chronic respiratory diseases are the second leading cause of death. A few key factors propelling the market growth include a robust healthcare system and increasing healthcare expenditures and technological advancement.
| Country | India |
|---|---|
| Market CAGR % (2023 to 2033) | -1.3% |
The active humidifier devices market in India is likely to register a CAGR of -1.3% during the forecast period, with a market share of over 50% across South Asia, as per the latest report of FMI. The leading factor that aided the market growth is the outbreak of the COVID-19 pandemic.
India witnessed a sudden spike in cases in the second wave, due to which the government increased the adoption of active humidifier devices to reduce the fatalities in the country.
Cases of coronavirus have abated in the country, leading to reduced demand for active humidifier devices. As a result, the country offers reduced opportunities for future growth. By the end of the forecast period, the market is expected to return to pre-covid levels.
| Segment | Electronic Humidifiers |
|---|---|
| Market Share % (2022) | 55.79% |
With the advent of advanced technology and innovation in recent years, active humidifier devices are growing and have become one of the most significant sectors in the healthcare industry. Based on product type, heated/electronic humidifier devices are expected to lead the segment in the global market, occupying a market share of more than 55.79% by the end of 2023.
Demand for heated/electronic heaters is expected to increase over the coming years as electric humidifiers also help people with dry skin and allergies. Moreover, the high prevalence of airborne diseases such as flu, influenza, and other diseases has surged the adoption of heated/electronic humidifier devices.
Medical researchers found that humidity levels above 40% significantly deactivate the virus and bacteria that cause airborne respiratory diseases. Hence, adoption of these devices is expected to surge over the coming years.
| Segment | Invasive Ventilation |
|---|---|
| Market Share % (2022) | 47% |
By application, the market is segregated into non-invasive ventilation, invasive ventilation, and high-flow oxygen therapy. As per Future Market Insights, the invasive ventilation segment is expected to be the dominant segment in the global active humidifier devices market in 2023, occupying a market share of more than 47% in 2023.
Following the outbreak of COVID-19, as the cases increased at an alarming rate, especially in developing economies such as India, the need for invasive ventilation increased the sales of active humidifier devices. Also, the demand for non-invasive ventilation among the geriatric population is expected to increase over the coming years. The segment is projected to account for over 31.3% of the market share by 2033.
Companies operating in the global active humidifier devices industry seek to invigorate their position through collaborations, partnerships, and agreements with established and emerging market players. Further, the acquisition significantly accelerates the manufacturer’s strategy to capitalize on the market share and capture a significant share of the market.
Key Developments Taking Place in the Market:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value, Units for Volume |
| Key Countries Covered | The United States, Canada, Germany, the United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, South Africa |
| Key Segments Covered | Product Type, Age Group, Application, End User, and Region |
| Key Companies Profiled | Fisher & Paykel Healthcare Limited; Koninklijke Philips N.V.(Philips Respironics); Vapotherm; Teleflex Corporation; ResMed Corporation; VINCENT MEDICAL HOLDINGS LIMITED; Armstrong Medical (an Eakin Company); Breas Medical AB (Subsidiary of Fosun Pharma); BMC Medical Co., Ltd; Hamilton Medical AG; SunMed; WILAmed GmbH; Flexicare (Group) Limited; Penlon Limited; DEAS S.R.L.; Intersurgical Ltd; Beijing Aeonmed Co., Ltd.; Shenyang RMS MEDICAL TECH CO., LTD; GaleMed Corporation; Vadi Medical Technology Co, Ltd. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The active humidifier devices market CAGR for 2033 is -0.5%.
The market is estimated to reach US$ 1,206.9 million by 2033.
The challenges in the active humidifier devices market are the cost, maintenance, and risk of mold growth.
The market is estimated to secure a valuation of US$ 1,264.4 million in 2023.
Increasing demand for indoor air quality improvement is the key challenge.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Heated/electronic Humidifiers 5.3.2. Bubble Humidifiers 5.3.3. Accessories 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Age Group 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Age Group, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Age Group, 2023 to 2033 6.3.1. Adult 6.3.2. Paediatric 6.3.3. Neonates 6.4. Y-o-Y Growth Trend Analysis By Age Group, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Age Group, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033 7.3.1. Invasive Ventilation 7.3.2. Non-invasive Ventilation 7.3.2.1. nCPAP (Nasal Continuous Positive Airway Pressure) 7.3.2.2. Bubble CPAP (Bubble Continuous Positive Airway Pressure) 7.3.3. High Flow Oxygen Therapy 7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 8.3.1. Hospitals 8.3.1.1. Less than 100 Beds 8.3.1.2. 100-300 Beds 8.3.1.3. 300-500 Beds 8.3.1.4. 500 Beds and More 8.3.2. Ambulatory Surgical Centers 8.3.3. Sleep Centres 8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. The USA 10.2.1.2. Canada 10.2.2. By Product Type 10.2.3. By Age Group 10.2.4. By Application 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Age Group 10.3.4. By Application 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Product Type 11.2.3. By Age Group 11.2.4. By Application 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Age Group 11.3.4. By Application 11.3.5. By End User 11.4. Key Takeaways 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. United Kingdom 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Product Type 12.2.3. By Age Group 12.2.4. By Application 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Age Group 12.3.4. By Application 12.3.5. By End User 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Product Type 13.2.3. By Age Group 13.2.4. By Application 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Age Group 13.3.4. By Application 13.3.5. By End User 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Product Type 14.2.3. By Age Group 14.2.4. By Application 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Age Group 14.3.4. By Application 14.3.5. By End User 14.4. Key Takeaways 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Product Type 15.2.3. By Age Group 15.2.4. By Application 15.2.5. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Age Group 15.3.4. By Application 15.3.5. By End User 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Product Type 16.2.3. By Age Group 16.2.4. By Application 16.2.5. By End User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Product Type 16.3.3. By Age Group 16.3.4. By Application 16.3.5. By End User 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Product Type 17.1.2.2. By Age Group 17.1.2.3. By Application 17.1.2.4. By End User 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Product Type 17.2.2.2. By Age Group 17.2.2.3. By Application 17.2.2.4. By End User 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Product Type 17.3.2.2. By Age Group 17.3.2.3. By Application 17.3.2.4. By End User 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Product Type 17.4.2.2. By Age Group 17.4.2.3. By Application 17.4.2.4. By End User 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Product Type 17.5.2.2. By Age Group 17.5.2.3. By Application 17.5.2.4. By End User 17.6. United Kingdom 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Product Type 17.6.2.2. By Age Group 17.6.2.3. By Application 17.6.2.4. By End User 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Product Type 17.7.2.2. By Age Group 17.7.2.3. By Application 17.7.2.4. By End User 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Product Type 17.8.2.2. By Age Group 17.8.2.3. By Application 17.8.2.4. By End User 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Product Type 17.9.2.2. By Age Group 17.9.2.3. By Application 17.9.2.4. By End User 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Product Type 17.10.2.2. By Age Group 17.10.2.3. By Application 17.10.2.4. By End User 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Product Type 17.11.2.2. By Age Group 17.11.2.3. By Application 17.11.2.4. By End User 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Product Type 17.12.2.2. By Age Group 17.12.2.3. By Application 17.12.2.4. By End User 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Product Type 17.13.2.2. By Age Group 17.13.2.3. By Application 17.13.2.4. By End User 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Product Type 17.14.2.2. By Age Group 17.14.2.3. By Application 17.14.2.4. By End User 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Product Type 17.15.2.2. By Age Group 17.15.2.3. By Application 17.15.2.4. By End User 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Product Type 17.16.2.2. By Age Group 17.16.2.3. By Application 17.16.2.4. By End User 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Product Type 17.17.2.2. By Age Group 17.17.2.3. By Application 17.17.2.4. By End User 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Product Type 17.18.2.2. By Age Group 17.18.2.3. By Application 17.18.2.4. By End User 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Product Type 17.19.2.2. By Age Group 17.19.2.3. By Application 17.19.2.4. By End User 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Product Type 17.20.2.2. By Age Group 17.20.2.3. By Application 17.20.2.4. By End User 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Product Type 17.21.2.2. By Age Group 17.21.2.3. By Application 17.21.2.4. By End User 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2022 17.22.2.1. By Product Type 17.22.2.2. By Age Group 17.22.2.3. By Application 17.22.2.4. By End User 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2022 17.23.2.1. By Product Type 17.23.2.2. By Age Group 17.23.2.3. By Application 17.23.2.4. By End User 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Product Type 18.3.3. By Age Group 18.3.4. By Application 18.3.5. By End User 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Fisher & Paykel Healthcare Limited 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.1.5.2. Product Strategy 19.1.1.5.3. Channel Strategy 19.1.2. Koninklijke Philips N.V.(Philips Respironics) 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.2.5.2. Product Strategy 19.1.2.5.3. Channel Strategy 19.1.3. Vapotherm 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.3.5.2. Product Strategy 19.1.3.5.3. Channel Strategy 19.1.4. Teleflex Corporation 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.4.5.2. Product Strategy 19.1.4.5.3. Channel Strategy 19.1.5. ResMed Corporation 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.5.5.2. Product Strategy 19.1.5.5.3. Channel Strategy 19.1.6. VINCENT MEDICAL HOLDINGS LIMITED 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.6.5.2. Product Strategy 19.1.6.5.3. Channel Strategy 19.1.7. Armstrong Medical (an Eakin Company) 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.7.5.2. Product Strategy 19.1.7.5.3. Channel Strategy 19.1.8. Breas Medical AB (Subsidiary of Fosun Pharma) 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.8.5.2. Product Strategy 19.1.8.5.3. Channel Strategy 19.1.9. BMC Medical Co., Ltd 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.9.5.2. Product Strategy 19.1.9.5.3. Channel Strategy 19.1.10. Hamilton Medical AG 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.10.5.2. Product Strategy 19.1.10.5.3. Channel Strategy 19.1.11. SunMed 19.1.11.1. Overview 19.1.11.2. Product Portfolio 19.1.11.3. Profitability by Market Segments 19.1.11.4. Sales Footprint 19.1.11.5. Strategy Overview 19.1.11.5.1. Marketing Strategy 19.1.11.5.2. Product Strategy 19.1.11.5.3. Channel Strategy 19.1.12. WILAmed GmbH 19.1.12.1. Overview 19.1.12.2. Product Portfolio 19.1.12.3. Profitability by Market Segments 19.1.12.4. Sales Footprint 19.1.12.5. Strategy Overview 19.1.12.5.1. Marketing Strategy 19.1.12.5.2. Product Strategy 19.1.12.5.3. Channel Strategy 19.1.13. Flexicare (Group) Limited 19.1.13.1. Overview 19.1.13.2. Product Portfolio 19.1.13.3. Profitability by Market Segments 19.1.13.4. Sales Footprint 19.1.13.5. Strategy Overview 19.1.13.5.1. Marketing Strategy 19.1.13.5.2. Product Strategy 19.1.13.5.3. Channel Strategy 19.1.14. Penlon Limited 19.1.14.1. Overview 19.1.14.2. Product Portfolio 19.1.14.3. Profitability by Market Segments 19.1.14.4. Sales Footprint 19.1.14.5. Strategy Overview 19.1.14.5.1. Marketing Strategy 19.1.14.5.2. Product Strategy 19.1.14.5.3. Channel Strategy 19.1.15. DEAS S.R.L. 19.1.15.1. Overview 19.1.15.2. Product Portfolio 19.1.15.3. Profitability by Market Segments 19.1.15.4. Sales Footprint 19.1.15.5. Strategy Overview 19.1.15.5.1. Marketing Strategy 19.1.15.5.2. Product Strategy 19.1.15.5.3. Channel Strategy 19.1.16. Intersurgical Ltd 19.1.16.1. Overview 19.1.16.2. Product Portfolio 19.1.16.3. Profitability by Market Segments 19.1.16.4. Sales Footprint 19.1.16.5. Strategy Overview 19.1.16.5.1. Marketing Strategy 19.1.16.5.2. Product Strategy 19.1.16.5.3. Channel Strategy 19.1.17. Beijing Aeonmed Co., Ltd. 19.1.17.1. Overview 19.1.17.2. Product Portfolio 19.1.17.3. Profitability by Market Segments 19.1.17.4. Sales Footprint 19.1.17.5. Strategy Overview 19.1.17.5.1. Marketing Strategy 19.1.17.5.2. Product Strategy 19.1.17.5.3. Channel Strategy 19.1.18. Shenyang RMS MEDICAL TECH CO., LTD 19.1.18.1. Overview 19.1.18.2. Product Portfolio 19.1.18.3. Profitability by Market Segments 19.1.18.4. Sales Footprint 19.1.18.5. Strategy Overview 19.1.18.5.1. Marketing Strategy 19.1.18.5.2. Product Strategy 19.1.18.5.3. Channel Strategy 19.1.19. GaleMed Corporation 19.1.19.1. Overview 19.1.19.2. Product Portfolio 19.1.19.3. Profitability by Market Segments 19.1.19.4. Sales Footprint 19.1.19.5. Strategy Overview 19.1.19.5.1. Marketing Strategy 19.1.19.5.2. Product Strategy 19.1.19.5.3. Channel Strategy 19.1.20. Vadi Medical Technology Co, Ltd. 19.1.20.1. Overview 19.1.20.2. Product Portfolio 19.1.20.3. Profitability by Market Segments 19.1.20.4. Sales Footprint 19.1.20.5. Strategy Overview 19.1.20.5.1. Marketing Strategy 19.1.20.5.2. Product Strategy 19.1.20.5.3. Channel Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Active Humidifier Devices Market
